» Articles » PMID: 31980677

Cell Release During Perfusion Reflects Cold Ischemic Injury in Rat Livers

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jan 26
PMID 31980677
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The global shortage of donor organs has made it crucial to deeply understand and better predict donor liver viability. However, biomarkers that effectively assess viability of marginal grafts for organ transplantation are currently lacking. Here, we showed that hepatocytes, sinusoidal endothelial, stellate, and liver-specific immune cells were released into perfusates from Lewis rat livers as a result of cold ischemia and machine perfusion. Perfusate comparison analysis of fresh livers and cold ischemic livers showed that the released cell profiles were significantly altered by the duration of cold ischemia. Our findings show for the first time that parenchymal cells are released from organs under non-proliferative pathological conditions, correlating with the degree of ischemic injury. Thus, perfusate cell profiles could serve as potential biomarkers of graft viability and indicators of specific injury mechanisms during organ handling and transplantation. Further, parenchymal cell release may have applications in other pathological conditions beyond organ transplantation.

Citing Articles

UW supplementation with AP39 improves liver viability following static cold storage.

Taggart M, Holkup S, Tchir A, Mojoudi M, Lyon A, Hassan M Sci Rep. 2025; 15(1):1559.

PMID: 39789174 PMC: 11718015. DOI: 10.1038/s41598-025-85302-w.


Single cell RNA-sequencing identifies the effect of Normothermic ex vivo liver perfusion on liver-resident T cells.

Al-Adra D, Lan R, Jennings H, Weinstein K, Liu Y, Verhoven B Transpl Immunol. 2024; 86:102104.

PMID: 39128812 PMC: 11387148. DOI: 10.1016/j.trim.2024.102104.


UW Supplementation with AP39 Improves Liver Viability Following Static Cold Storage.

McLean S, Holkup S, Tchir A, Mojoudi M, Hassan M, Taveras C Res Sq. 2024; .

PMID: 38947096 PMC: 11213193. DOI: 10.21203/rs.3.rs-4487319/v1.


Innate Immune Cells during Machine Perfusion of Liver Grafts-The Janus Face of Hepatic Macrophages.

Roushansarai N, Pascher A, Becker F J Clin Med. 2022; 11(22).

PMID: 36431146 PMC: 9696117. DOI: 10.3390/jcm11226669.


The liver-resident immune cell repertoire - A boon or a bane during machine perfusion?.

Fodor M, Salcher S, Gottschling H, Mair A, Blumer M, Sopper S Front Immunol. 2022; 13:982018.

PMID: 36311746 PMC: 9609784. DOI: 10.3389/fimmu.2022.982018.


References
1.
Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

2.
Kim W, Lake J, Smith J, Schladt D, Skeans M, Noreen S . OPTN/SRTR 2017 Annual Data Report: Liver. Am J Transplant. 2019; 19 Suppl 2:184-283. DOI: 10.1111/ajt.15276. View

3.
Giwa S, Lewis J, Alvarez L, Langer R, Roth A, Church G . The promise of organ and tissue preservation to transform medicine. Nat Biotechnol. 2017; 35(6):530-542. PMC: 5724041. DOI: 10.1038/nbt.3889. View

4.
Abt P, Desai N, Crawford M, Forman L, Markmann J, Olthoff K . Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2003; 239(1):87-92. PMC: 1356197. DOI: 10.1097/01.sla.0000103063.82181.2c. View

5.
Feng S, Goodrich N, Bragg-Gresham J, Dykstra D, Punch J, DebRoy M . Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006; 6(4):783-90. DOI: 10.1111/j.1600-6143.2006.01242.x. View